TREM2 inhibits cholangiocarcinoma progression by regulating the TGF-β/Smad2/3 signaling pathway
American Journal of Cancer Research · 2026 · 16 (2) · 402-417
DOI: 10.62347/bylb7175 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Cancer Research, 2026. Verfasst von Xia Lei und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The Lanzhou University Second Hospital Lanzhou, Gansu, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, The Lanzhou University Second Hospital Lanzhou, Gansu, China.
Zitieren
APA
Lei, X., Hao, J., Gou, Y., & Huang, X. (2026). TREM2 inhibits cholangiocarcinoma progression by regulating the TGF-β/Smad2/3 signaling pathway. American Journal of Cancer Research, 16(2), 402-417. https://doi.org/10.62347/bylb7175
Vancouver
Lei X, Hao J, Gou Y, Huang X. TREM2 inhibits cholangiocarcinoma progression by regulating the TGF-β/Smad2/3 signaling pathway. American Journal of Cancer Research. 2026;16(2):402-417. doi:10.62347/bylb7175
BibTeX
@article{Lei2026,
author = {Lei, Xia and Hao, Jinyong and Gou, Yani and Huang, Xiaojun},
title = {TREM2 inhibits cholangiocarcinoma progression by regulating the TGF-β/Smad2/3 signaling pathway},
journal = {American Journal of Cancer Research},
year = {2026},
volume = {16},
number = {2},
pages = {402--417},
doi = {10.62347/bylb7175}
}
EUVIMED